查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1790344

美國解剖病理學市場規模、佔有率和趨勢分析報告（按產品/服務、應用、最終用途和細分市場預測，2025 年至 2030 年）

U.S. Anatomic Pathology Market Size, Share & Trends Analysis Report By Product & Services (Instruments, Consumables, Services), By Application (Disease Diagnosis, Drug Discovery & Development), By End Use, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

美國解剖病理學市場概況

美國解剖病理學市場規模預計在 2024 年為 97.1 億美元，預計到 2030 年將達到 153.5 億美元，2025 年至 2030 年的複合年成長率為 7.1%。在技術創新和不斷成長的臨床需求的推動下，該市場正在經歷強勁成長。

在分析前、分析中和分析後等所有階段整合自動化和數位化解決方案，是提高診斷準確性、效率和患者預後的關鍵。先進病理學設備（包括大體成像系統、數位顯微鏡和自動染色平台）的日益整合，有望提升解剖病理學實踐。

尤其是數位成像技術，與傳統方法相比，顯著提高了診斷的特異性和準確性。因此，由於對更準確、更可靠的診斷服務的需求不斷成長，解剖病理學市場正在迅速採用這些數位解決方案。 2023年3月，PathAI, Inc. 推出了 AISight 數位病理平台和 AIM-PD-L1 NSCLC RUO 演算法。 13個主要的醫療系統、學術醫療中心、獨立病理組織和參考實驗室參與了 AISight 早期訪問計劃。

美國個人化醫療和精準醫療的發展極大地推動了對解剖病理學服務的需求。隨著治療方案越來越針對患者的個別基因和分子特徵進行量身定做，準確而詳細的組織分析至關重要。解剖病理學家發揮核心作用，他們對活體組織切片和手術標本進行專門檢測，包括免疫組織化學 (IHC)、原位雜合反應和次世代定序(NGS)，以檢測重要的生物標記，例如切片檢查、EGFR 、KRAS 和檢體。這些結果直接指導乳癌、肺癌和大腸直腸癌標靶治療的選擇。

美國解剖病理學市場細分

本報告預測了2018年至2030年各國各國的收益成長，並分析了每個細分領域的最新行業趨勢。在本研究中，Grand View Research, Inc. 根據產品/服務、應用和最終用途對美國解剖病理學市場報告進行了細分。

目錄

第1章調查方法與範圍

第2章執行摘要

第3章美國解剖病理學市場變數、趨勢與範圍

  • 市場體系展望
    • 母市場展望
    • 相關/附隨市場展望
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 美國解剖病理學市場分析工具
    • 產業分析—波特五力分析
    • PESTEL分析
  • 美國解剖病理學市場：通路分析

第4章美國解剖病理學市場：按產品和服務的估計和趨勢分析

  • 產品和服務細分儀表板
  • 美國解剖病理學市場：產品與服務差異分析
  • 2018 年至 2030 年美國解剖病理學市場規模及趨勢分析（依產品及服務）
  • 裝置
    • 切片機和低溫恒溫器切片機
    • 組織處理器
    • 自動過濾器
    • 全幻燈片成像（WSI）掃描儀
    • 其他
  • 耗材
    • 試劑和抗體
    • 探針和套件
    • 其他
  • 服務

第5章美國解剖病理學市場的應用、估計與趨勢分析

  • 應用程式細分儀表板
  • 美國解剖病理學市場：應用變異分析
  • 2018-2030年美國解剖病理學市場規模及應用趨勢分析
  • 疾病診斷
  • 藥物研發
  • 其他

第6章美國解剖病理學市場最終用途、估計與趨勢分析

  • 最終用途細分儀表板
  • 美國解剖病理學市場：最終用途變異分析
  • 2018-2030 年美國解剖病理學市場規模及趨勢分析（依最終用途）
  • 醫院
  • 實驗室
  • 診斷實驗室
  • 其他

第7章 競爭態勢

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司/競爭對手分類
  • 供應商格局
    • 2024年主要企業熱圖分析
  • 公司簡介
    • Danaher Corporation
    • Quest Diagnostics Incorporated
    • Labcorp
    • Agilent Technologies, Inc.
    • Cardinal Health
    • Sakura Finetek USA, Inc.
    • NeoGenomics Laboratories, Inc.
    • BioGenex
    • Bio SB
Product Code: GVR-4-68040-664-2

U.S. Anatomic Pathology Market Summary

The U.S. anatomic pathology market size was estimated at USD 9.71 billion in 2024 and is projected to reach USD 15.35 billion by 2030, growing at a CAGR of 7.1% from 2025 to 2030. This market is experiencing robust growth driven by technological innovation and growing clinical demands.

Integrating automation and digital solutions across all phases, such as pre-analytical, analytical, and post-analytical, is key to enhancing diagnostic accuracy, efficiency, and patient outcomes. The growing integration of advanced pathology equipment, such as gross imaging systems, digital microscopes, and automated staining platforms, is poised to enhance anatomic pathology practices.

Digital imaging technologies, in particular, deliver notable improvements in diagnostic specificity and accuracy over traditional methods. Consequently, the market for anatomic pathology is witnessing a surge in the adoption of these digital solutions, fueled by rising demand for diagnostic services that offer greater precision and reliability. In March 2023, PathAI, Inc. launched its AISight digital pathology platform and AIM-PD-L1 NSCLC RUO algorithm. Thirteen leading health systems, academic medical centers, and independent pathology organizations and reference laboratories participated in AISight Early Access Program.

The growth of personalized and precision medicine in the U.S. significantly fuels demand for anatomic pathology services. Accurate and detailed tissue analysis has become essential as more treatments become tailored to a patient's individual genetic and molecular profile. Anatomic pathologists play a central role by performing specialized testing on biopsy and surgical specimens-including immunohistochemistry (IHC), in situ hybridization, and next-generation sequencing (NGS)-to detect key biomarkers such as HER2, EGFR, KRAS, and PD-L1. These results directly guide the selection of targeted therapies in breast, lung, and colorectal cancers.

U.S. Anatomic Pathology Market Segmentation

This report forecasts revenue growth at country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. anatomic pathology market report based on product & services, application, and end use.

  • Product & Services Outlook (Revenue, USD Billion, 2018 - 2030)
  • Instruments
    • Microtomes & Cryostat microtomes
    • Tissue processors
    • Automatic strainers
    • Whole Slide Imaging (WSI) Scanners
    • Other products
  • Consumables
    • Reagents & Antibodies
    • Probes & Kits
    • Others
  • Services
  • Application Outlook (Revenue, USD Billion, 2018 - 2030)
  • Disease Diagnosis
  • Drug Discovery and Development
  • Others
  • End Use Outlook (Revenue, USD Billion, 2018 - 2030)
  • Hospitals
  • Research Laboratories
  • Diagnostic Laboratories
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product & Services
    • 1.2.2. Application
    • 1.2.3. End Use
    • 1.2.4. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market formulation & Validation
  • 1.7. Model Details
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product & services outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
  • 2.3. Competitive Insights

Chapter 3. U.S. Anatomic Pathology Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
    • 3.2.2. Market restraint analysis
  • 3.3. U.S. Anatomic Pathology Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape
  • 3.4. U.S. Anatomic Pathology Market: Pipeline Analysis

Chapter 4. U.S. Anatomic Pathology Market: Product & Services Estimates & Trend Analysis

  • 4.1. Product & Services Segment Dashboard
  • 4.2. U.S. Anatomic Pathology Market: Product & Services Movement Analysis
  • 4.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by Product & Services, 2018 to 2030 (USD Billion)
  • 4.4. Instruments
    • 4.4.1. Microtomes & Cryostat microtomes
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.2. Tissue processors
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.3. Automatic strainers
      • 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.4. Whole Slide Imaging (WSI) Scanners
      • 4.4.4.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.4.5. Other products
      • 4.4.5.1. Market estimates and forecasts 2018 to 2030 (USD billion)
  • 4.5. Consumables
    • 4.5.1. Reagents & Antibodies
      • 4.5.1.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.5.2. Probes & Kits
      • 4.5.2.1. Market estimates and forecasts 2018 to 2030 (USD billion)
    • 4.5.3. Others
      • 4.5.3.1. Market estimates and forecasts 2018 to 2030 (USD billion)
  • 4.6. Services
    • 4.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 5. U.S. Anatomic Pathology Market: Application Estimates & Trend Analysis

  • 5.1. Application Segment Dashboard
  • 5.2. U.S. Anatomic Pathology Market: Application Movement Analysis
  • 5.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Billion)
  • 5.4. Disease Diagnosis
    • 5.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.5. Drug Discovery and Development
    • 5.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 5.6. Others
    • 5.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 6. U.S. Anatomic Pathology Market: End Use Estimates & Trend Analysis

  • 6.1. End Use Segment Dashboard
  • 6.2. U.S. Anatomic Pathology Market: End Use Movement Analysis
  • 6.3. U.S. Anatomic Pathology Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Billion)
  • 6.4. Hospitals
    • 6.4.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.5. Research Laboratories
    • 6.5.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.6. Diagnostic Laboratories
    • 6.6.1. Market estimates and forecasts 2018 to 2030 (USD Billion)
  • 6.7. Others
    • 6.7.1. Market estimates and forecasts 2018 to 2030 (USD Billion)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 7.2. Company/Competition Categorization
  • 7.3. Vendor Landscape
    • 7.3.1. Key company heat map analysis, 2024
  • 7.4. Company Profiles
    • 7.4.1. Danaher Corporation
      • 7.4.1.1. Company overview
      • 7.4.1.2. Financial performance
      • 7.4.1.3. Product benchmarking
      • 7.4.1.4. Strategic initiatives
    • 7.4.2. Quest Diagnostics Incorporated
      • 7.4.2.1. Company overview
      • 7.4.2.2. Financial performance
      • 7.4.2.3. Product benchmarking
      • 7.4.2.4. Strategic initiatives
    • 7.4.3. Labcorp
      • 7.4.3.1. Company overview
      • 7.4.3.2. Financial performance
      • 7.4.3.3. Product benchmarking
      • 7.4.3.4. Strategic initiatives
    • 7.4.4. Agilent Technologies, Inc.
      • 7.4.4.1. Company overview
      • 7.4.4.2. Financial performance
      • 7.4.4.3. Product benchmarking
      • 7.4.4.4. Strategic initiatives
    • 7.4.5. Cardinal Health
      • 7.4.5.1. Company overview
      • 7.4.5.2. Financial performance
      • 7.4.5.3. Product benchmarking
      • 7.4.5.4. Strategic initiatives
    • 7.4.6. Sakura Finetek USA, Inc.
      • 7.4.6.1. Company overview
      • 7.4.6.2. Financial performance
      • 7.4.6.3. Product benchmarking
      • 7.4.6.4. Strategic initiatives
    • 7.4.7. NeoGenomics Laboratories, Inc.
      • 7.4.7.1. Company overview
      • 7.4.7.2. Financial performance
      • 7.4.7.3. Product benchmarking
      • 7.4.7.4. Strategic initiatives
    • 7.4.8. BioGenex
      • 7.4.8.1. Company overview
      • 7.4.8.2. Financial performance
      • 7.4.8.3. Product benchmarking
      • 7.4.8.4. Strategic initiatives
    • 7.4.9. Bio SB
      • 7.4.9.1. Company overview
      • 7.4.9.2. Financial performance
      • 7.4.9.3. Product benchmarking
      • 7.4.9.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviations
  • Table 2 U.S. anatomic pathology market, by product & services, 2018 - 2030 (USD Billion)
  • Table 3 U.S. anatomic pathology market, by application, 2018 - 2030 (USD Billion)
  • Table 4 U.S. anatomic pathology market, by end use, 2018 - 2030 (USD Billion)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 QFD modeling for market share assessment
  • Fig. 8 Market formulation & validation
  • Fig. 9 U.S. anatomic pathology market: market outlook
  • Fig. 10 U.S. anatomic pathology competitive insights
  • Fig. 11 Parent market outlook
  • Fig. 12 Related/ancillary market outlook
  • Fig. 13 Penetration and growth prospect mapping
  • Fig. 14 Industry value chain analysis
  • Fig. 15 U.S. anatomic pathology market driver impact
  • Fig. 16 U.S. anatomic pathology market restraint impact
  • Fig. 17 U.S. anatomic pathology market strategic initiatives analysis
  • Fig. 18 U.S. anatomic pathology market: Product & services movement analysis
  • Fig. 19 U.S. anatomic pathology market: Product & services outlook and key takeaways
  • Fig. 20 Instruments market estimates and forecasts, 2018 - 2030
  • Fig. 21 Microtomes & cryostat microtomes market estimates and forecasts, 2018 - 2030
  • Fig. 22 Tissue processors market estimates and forecasts, 2018 - 2030
  • Fig. 23 Automatic strainers market estimates and forecasts, 2018 - 2030
  • Fig. 24 Whole Slide Imaging (WSI) scanners market estimates and forecasts, 2018 - 2030
  • Fig. 25 Other products market estimates and forecasts, 2018 - 2030
  • Fig. 26 Consumables market estimates and forecasts, 2018 - 2030
  • Fig. 27 Reagents & antibodies market estimates and forecasts, 2018 - 2030
  • Fig. 28 Probes & kits market estimates and forecasts, 2018 - 2030
  • Fig. 29 Others market estimates and forecasts, 2018 - 2030
  • Fig. 30 Services market estimates and forecasts, 2018 - 2030
  • Fig. 31 U.S. anatomic pathology market: Application movement analysis
  • Fig. 32 U.S. anatomic pathology market: Application outlook and key takeaways
  • Fig. 33 Disease diagnosis market estimates and forecasts, 2018 - 2030
  • Fig. 34 Drug discovery and development market estimates and forecasts, 2018 - 2030
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030
  • Fig. 36 U.S. anatomic pathology market: End use movement analysis
  • Fig. 37 U.S. anatomic pathology market: End use outlook and key takeaways
  • Fig. 38 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 39 Research laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 40 Diagnostic laboratories market estimates and forecasts, 2018 - 2030
  • Fig. 41 Others market estimates and forecasts, 2018 - 2030